Recruiting

A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes.

I8B-MC-ITSZ - ClinicalTrials.gov - NCT04585776

The reason for this study is to evaluate the amount of time with glucose values within target range.
How long will I be in the trial?
The study will last about 74 days and may include up to 15 visits.
Email
Recruiting

A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes.

I8B-MC-ITSZ - ClinicalTrials.gov - NCT04585776

The reason for this study is to evaluate the amount of time with glucose values within target range.
How long will I be in the trial?
The study will last about 74 days and may include up to 15 visits.
Email

Key Requirements

Age :

18-65

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-65

Sex

All

Participants must

Participants must have type 1 diabetes and have been treated with insulin therapy for at least 1 year

Participants must be using Dexcom G5 or G6 Continuous Glucose Monitoring (CGM) and with a total CGM use ≥ 6 months in the prior year

Participants must have been on the same type of short acting insulin (Humalog U-100 or Novolog) for at least 30 days prior to screening

Participants must have been treated with long-acting insulin degludec U-100 for at least 30 days prior to screening

Participants must NOT

Participants must not have had more than 1 emergency room visit or hospitalization due to poor glucose control within 6 months before screening

Participants must not have had more than 1 episode of severe hypoglycemia within the last 90 days prior to screening

Participants must not be taking certain diabetes medications that are not allowed for study participation

Trial Summary

Conditions the trial is for

Type 1 Diabetes

What the trial is testing?

LY9000014, Insulin Degludec

Could I receive a Placebo?

no

Enrollment Goal

34

Trial Dates

October 2020 - March 2021

Trial Phase

2

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-65

Sex

All

Participants must

Participants must have type 1 diabetes and have been treated with insulin therapy for at least 1 year

Participants must be using Dexcom G5 or G6 Continuous Glucose Monitoring (CGM) and with a total CGM use ≥ 6 months in the prior year

Participants must have been on the same type of short acting insulin (Humalog U-100 or Novolog) for at least 30 days prior to screening

Participants must have been treated with long-acting insulin degludec U-100 for at least 30 days prior to screening

Participants must NOT

Participants must not have had more than 1 emergency room visit or hospitalization due to poor glucose control within 6 months before screening

Participants must not have had more than 1 episode of severe hypoglycemia within the last 90 days prior to screening

Participants must not be taking certain diabetes medications that are not allowed for study participation

Trial Summary

Conditions the trial is for

Type 1 Diabetes

What the trial is testing?

LY9000014, Insulin Degludec

Could I receive a Placebo?

no

Enrollment Goal

34

Trial Dates

October 2020 - March 2021

Trial Phase

2

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Type 1 Diabetes Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?